A boxed warning alerts doctors and patients about drug effects that may be dangerous. If you have a history of cardiovascular disease, you should only use febuxostat to treat your gout in two ...

Febuxostat tablets are indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol. Lupin has ...

Febuxostat 40 mg daily appears to be as efficacious as allopurinol in lowering serum uric acid levels. [38] Both febuxostat 40 and 80 mg can be given to patients with mild-to-moderate renal impair ...

Febuxostat is still being produced by a number of generic manufacturers. Takeda Pharmaceuticals will no longer be manufacturing Uloric (febuxostat), according to a discontinuation notice posted to ...

The FDA has approved generic febuxostat 40 mg and 80 mg tablets for managing chronic hyperuricemia. The annual U.S. market for the drug is estimated at $27 million, according to its manufacturer.

Patients who were randomly assigned to receive febuxostat initially received 40 mg once daily and continued to receive this dose if the serum urate level was less than 6.0 mg per deciliter after 2 ...

Aurobindo has received the Food and Drug Administration’s permission for febuxostat tablets, 40 mg and 80 mg, which are the generic of Takeda’s Uloric. Febuxostat tablets are indicated for the ...

Febuxostat (Goustat) is a xanthine oxidase (XO) inhibitor, prescribed for gout and hyperuricemia (high level of uric acid in blood). It decreases the amount of uric acid in blood. The information ...

The drugs each have a lengthy history, with allopurinol earning approval from the US Food and Drug Administration (FDA) in 1966 and febuxostat (Uloric, Takeda) in 2009. CARES, a noninferiority trial, ...

Dotinurad 4 mg/d is more effective in reducing serum urate levels than febuxostat 40 mg/d at week 24 in patients with gout, a ...

The primary study endpoint was the proportion of patients who achieved a target SU level of less than 6 mg/dL after treatment with febuxostat. For patients with impaired renal function ...

Febuxostat (Feboxa) is a xanthine oxidase (XO) inhibitor, prescribed for gout and hyperuricemia (high level of uric acid in blood). It decreases the amount of uric acid in blood. The information ...